Mei-Jung Lai

Affiliations: 
2010 College of Pharmacy Taipei Medical University 
Google:
"Mei-Jung Lai"
Mean distance: (not calculated yet)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Sharma R, Chiang YH, Chen HC, et al. (2024) Dual inhibition of CYP17A1 and HDAC6 by abiraterone-installed hydroxamic acid overcomes temozolomide resistance in glioblastoma through inducing DNA damage and oxidative stress. Cancer Letters. 216666
Sharma S, Wang SA, Yang WB, et al. (2024) First-in-Class Dual EZH2-HSP90 Inhibitor Eliciting Striking Antiglioblastoma Activity and . Journal of Medicinal Chemistry
Tsai FL, Huang HL, Lai MJ, et al. (2023) Anticancer Study of a Novel Pan-HDAC Inhibitor MPT0G236 in Colorectal Cancer Cells. International Journal of Molecular Sciences. 24
Narwanti I, Yu ZY, Sethy B, et al. (2023) 6-Regioisomeric 5,8-quinolinediones as potent CDC25 inhibitors against colorectal cancers. European Journal of Medicinal Chemistry. 258: 115505
Tseng HJ, Banerjee S, Qian B, et al. (2023) Design, synthesis, and biological activity of dual monoamine oxidase A and heat shock protein 90 inhibitors, N-Methylpropargylamine-conjugated 4-isopropylresorcinol for glioblastoma. European Journal of Medicinal Chemistry. 256: 115459
Lai MJ, Lee HY, Chuang HY, et al. (2023) Correction to "-Sulfonyl-aminobiaryls as Antitubulin Agents and Inhibitors of Signal Transducers and Activators of Transcription 3 (STAT3) Signaling". Journal of Medicinal Chemistry
Nepali K, Wu AC, Lo WL, et al. (2023) Rationally designed donepezil-based hydroxamates modulate Sig-1R and HDAC isoforms to exert anti-glioblastoma effects. European Journal of Medicinal Chemistry. 248: 115054
Hsu TJ, Nepali K, Tsai CH, et al. (2021) The HDAC/HSP90 Inhibitor G570 Attenuated Blue Light-Induced Cell Migration in RPE Cells and Neovascularization in Mice through Decreased VEGF Production. Molecules (Basel, Switzerland). 26
Liu YM, Tu HJ, Wu CH, et al. (2021) Ring-opening of five-membered heterocycles conjugated 4-isopropylresorcinol scaffold-based benzamides as HSP90 inhibitors suppressing tumor growth in vitro and in vivo. European Journal of Medicinal Chemistry. 219: 113428
Nepali K, Hsu TI, Hsieh CM, et al. (2021) Pragmatic recruitment of memantine as the capping group for the design of HDAC inhibitors: A preliminary attempt to unravel the enigma of glioblastoma. European Journal of Medicinal Chemistry. 217: 113338
See more...